4//SEC Filing
Hunter Robert Merrill 4
Accession 0001104659-13-003848
CIK 0001142380other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:47 PM ET
Size
5.0 KB
Accession
0001104659-13-003848
Insider Transaction Report
Form 4
Hunter Robert Merrill
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2013-01-17−21,891,922→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 20, 2012, as amended October 15, 2012, by and between Synergy Pharmaceuticals Inc ("Synergy") and Callisto Pharmaceuticals, Inc. ("Callisto"), Callisto merged with and into Synergy (the "Merger"). Upon the effective time of the Merger, each share of Callisto common stock was cancelled and exchanged for .1799 shares of Synergy common stock (the "Exchange Ratio").
Documents
Issuer
CALLISTO PHARMACEUTICALS INC
CIK 0001142380
Entity typeother
Related Parties
1- filerCIK 0001507797
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 4:47 PM ET
- Size
- 5.0 KB